Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AVACINCAPTAD PEGOL for Macular degeneration: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 7 adverse event reports in the FDA FAERS database where AVACINCAPTAD PEGOL was used for Macular degeneration.

Most Reported Side Effects for AVACINCAPTAD PEGOL

Side Effect Reports % Deaths Hosp.
Needle issue 21 10.4% 0 0
Intercepted product preparation error 20 9.9% 0 0
No adverse event 19 9.4% 0 0
Off label use 17 8.4% 0 0
Eye pain 16 7.9% 0 0
Vision blurred 16 7.9% 0 0
Syringe issue 15 7.4% 0 0
Visual impairment 14 6.9% 0 0
Endophthalmitis 13 6.4% 0 0
Eye inflammation 12 5.9% 0 0
Intraocular pressure increased 12 5.9% 0 0
Vitritis 11 5.5% 0 0
Device issue 10 5.0% 0 0
Vitreous floaters 10 5.0% 0 0
Uveitis 9 4.5% 0 0

Other Indications for AVACINCAPTAD PEGOL

Dry age-related macular degeneration (93) Product used for unknown indication (87) Age-related macular degeneration (13)

Other Drugs Used for Macular degeneration

AFLIBERCEPT (945) RANIBIZUMAB (637) BEVACIZUMAB (442) MINERALS\VITAMINS (129) FLUOCINOLONE ACETONIDE (117) FARICIMAB\FARICIMAB-SVOA (111) FARICIMAB-SVOA (67) BROLUCIZUMAB-DBLL (51) LUCENTIS (51) DEXAMETHASONE (43)

Related Pages

AVACINCAPTAD PEGOL Full Profile All Macular degeneration Drugs AVACINCAPTAD PEGOL Demographics AVACINCAPTAD PEGOL Timeline